Literature DB >> 12527

Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.

D J Heal, A R Green, D J Boullin, D G Grahame-Smith.   

Abstract

Injection of tranylcypromine and L-tryptophan results in rats displaying behavioural changes including hyperactivity, probably due to stimulation of post-synaptic 5-hydroxytryptamine (5-HT) receptors. Increased locomotor activity of a different type is elicited by injection of tranylcypromine and L-dopa, a procedure which increased dopaminergic function in the brain. It has now been demonstrated that the neuroleptic drugs, chlorpromazine, alpha-flupenthixol, haloperidol and spiroperidol block both syndromes. The inhibition produced by these drugs on 5-HT-induced hyperactivity is probably because a dopaminergic system is involved in the behavioural expression of the 5-HT induced hyperactivity. The structurally related drugs with no neuroleptic activity (ethopropazine, promethazine and beta-flupenthixol)are without effect on thses hyperactivity syndromes. Also ineffective were the neuroleptics pimozide and clozapine. Striatal dopamine sensitive adenylate cyclase activity in vitro was inhibited by the administration of chlorpromazine (100 mg/kg) in vivo. Rats treated for 4 or more days with chlorpromazine, alpha-flupenthixol, spiroperidol and haloperidol subsequently showed enhanced locomotor activity in response to tranylcypromine and L-Dopa. Administration of those drugs which did not block hyperactivity acutely did not result in enhancement. Only chlorpromazine, when given for 4 days, enhanced the hyperactivity response following tranylcypromine and L-tryptophan, probably because the drug also blocks 5-HT receptors. In rats displaying enhanced behavioural responses no evidence was found for enhanced sensitivity of striatal adenylate cyclase to dopamine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 12527     DOI: 10.1007/BF00426832

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  47 in total

1.  Dopaminergic supersensitivity in the striatum.

Authors:  U Ungerstedt; T Ljungberg; B Hoffer; G Siggins
Journal:  Adv Neurol       Date:  1975

2.  Antimuscarinic actions of neuroleptic drugs.

Authors:  R Miller; R Hiley
Journal:  Adv Neurol       Date:  1975

3.  Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and the drug-induced rotation of rats.

Authors:  P H Kelly
Journal:  Brain Res       Date:  1975-12-12       Impact factor: 3.252

4.  The interaction of neuroleptic and muscarinic agents with central dopaminergic systems.

Authors:  P H Kelly; R J Miller
Journal:  Br J Pharmacol       Date:  1975-05       Impact factor: 8.739

5.  Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

6.  Thin-layer chromatography of chlorpromazine metabolites. Attempt to identify each of the metabolites appearing in blood, urine and feces of chronically medicated schizophrenics.

Authors:  P Turano; W J Turner; A A Manian
Journal:  J Chromatogr       Date:  1973-01-17

Review 7.  Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine.

Authors:  A R Green; D G Grahame-Smith
Journal:  Nature       Date:  1976-04-08       Impact factor: 49.962

8.  Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.

Authors:  D G Grahame-Smith
Journal:  J Neurochem       Date:  1971-06       Impact factor: 5.372

9.  Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity.

Authors:  R K Mishra; E L Gardner; R Katzman; M H Makman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

10.  Serotonin-sensitive adenylate cyclase activity of immature rat brain.

Authors:  K von Hungen; S Roberts; D F Hill
Journal:  Brain Res       Date:  1975-02-07       Impact factor: 3.252

View more
  13 in total

1.  Interactions between central monoaminergic systems: dopamine-serotonin.

Authors:  G Roccatagliata; C Albano; L Cocito; M Maffini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-12       Impact factor: 10.154

2.  Neuroleptic drugs block both the hyperactivity and the increase in caudate nucleus cyclic AMP concentration produced by the administration of tranylcypromine and L-dopa to rats.

Authors:  D J Heal; A R Green; M R Bloomfield; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1978-04-28       Impact factor: 4.530

Review 3.  Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.

Authors:  G B Baker; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

4.  Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment.

Authors:  J Hyttel
Journal:  Psychopharmacology (Berl)       Date:  1978-12-08       Impact factor: 4.530

Review 5.  Dopaminergic supersensitivity after neuroleptics: time-course and specificity.

Authors:  P Muller; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

6.  Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.

Authors:  A J Sleight; C A Marsden; K F Martin; M G Palfreyman
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

7.  A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.

Authors:  A R Green; J E Hall; A R Rees
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

8.  beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.

Authors:  D W Costain; A R Green
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

9.  Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat.

Authors:  E L Gardner; L S Walker; W Paredes
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  The effect of haloperidol, spiperone and pimozide on the flexor reflex of the hind limb of the spinal rat.

Authors:  J Maj; W Palider; A Rawłów
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.